India Slashes TB Deaths by 38% as Cure Rates Hit 94%

Published on Nov 13, 2026

3 min read

India Slashes TB Deaths by 38% as Cure Rates Hit 94% - OC Academy Medical Insights

"India achieves a 38% TB mortality decline and a 94% cure rate according to WHO, driven by AI screening and proactive case finding under NTEP."

India has achieved a significant milestone in tuberculosis control. According to the World Health Organization's Global Tuberculosis Report 2026, the country recorded a remarkable 38% TB mortality decline since 2015. Consequently, India's mortality rate fell from 28 per lakh population in 2015 to 18 per lakh in 2025. This performance notably outpaces the global average reduction of 35%. Furthermore, India achieved an impressive 94% treatment success rate among patients with drug-susceptible tuberculosis. Therefore, these outcomes demonstrate substantial progress under the National TB Elimination Programme (NTEP).

Key Factors Behind the TB Mortality Decline

Several programmatic interventions drove this sharp reduction in mortality. First, health authorities implemented aggressive active case finding nationwide under the TB Mukt Bharat Abhiyaan. Between December 2024 and November 2026, healthcare workers screened over 25 crore individuals. Through this initiative, teams identified 48.64 lakh new cases. Significantly, this total included nearly 15 lakh asymptomatic cases. Early diagnosis prevented advanced disease presentation and fatal complications. In addition, prompt therapy initiation prevented transmission across high-risk communities. Moreover, the programme ensured robust nutritional support via the Ni-kshay Poshan Yojana and Ni-kshay Mitra partnerships. Thus, comprehensive patient support lowered treatment default rates substantially.

Technological Innovations in TB Case Finding

Technology has fundamentally modernized India's diagnostic landscape. Specifically, field teams deployed portable, artificial intelligence-enabled digital chest X-rays in remote areas. These portable units quickly flag suspicious lung lesions on site. Subsequently, clinicians confirm suspected cases using rapid molecular diagnostics. The campaign facilitated more than 11 crore chest X-rays and three crore nucleic acid amplification tests (NAAT). As a result, diagnostic delays dropped sharply across both rural and urban centers. Furthermore, AI chatbots like Khushi and predictive algorithms identify transmission hotspots. Consequently, health authorities allocate therapeutic resources where clinicians need them most.

Clinical Implications for Healthcare Providers

For practicing physicians in India, these findings offer vital practice lessons. First, clinicians should maintain a low index of suspicion for asymptomatic presentations. Many patients in active screening cohorts exhibit minimal symptoms despite active disease. Therefore, integrating digital screening and NAAT early remains crucial. In addition, doctors must emphasize treatment adherence to sustain high cure rates. Nutritional evaluation should accompany standard antimicrobial regimens for every patient. Meanwhile, close monitoring ensures early identification of drug resistance or adverse drug reactions. Ultimately, combining modern molecular diagnostics with differentiated patient care will help achieve complete tuberculosis elimination.

Frequently Asked Questions

Q1: What contributed to India's 38% decline in TB mortality?

The progress stems from intensified screening, AI-enabled chest X-rays, molecular testing, prompt treatment initiation, and nutritional support programs.

Q2: What is India's current treatment success rate for drug-susceptible TB?

According to the WHO Global Tuberculosis Report 2026, India achieved a 94% treatment success rate among patients with drug-susceptible tuberculosis.

Q3: Why is asymptomatic screening important in clinical practice?

Intensified screening detected nearly 15 lakh asymptomatic cases. This underscores that early radiographic and molecular testing identifies active infection before noticeable clinical deterioration occurs.

References

India records 38% decline in TB mortality, treatment success rate rises to 94%:WHO - ETHealthworld
World Health Organization. Global Tuberculosis Report 2026. Geneva: WHO; 2026.
Ministry of Health and Family Welfare, Government of India. India Makes Major Strides Towards TB Elimination: 38% Decline in TB Mortality, 94% Treatment Success Rate. Press Information Bureau; 2026.